Related topics: genes · protein

New algorithm cleans microbiome data with unprecedented efficiency

None of us are born with a fully functioning immune system, and the first few months of life are crucial for establishing strong lifelong defenses. Better understanding how germs influence the development of human immunology ...

New method enables study of nano-sized particles

Researchers at Karolinska Institutet have created a new method of studying the smallest bioparticles in the body. The study, which is published in Nature Biotechnology, has considerable scientific potential, such as in the ...

Solving a crucial bottleneck in drug discovery

Many existing antibiotics were derived from soil bacteria, which naturally produce these toxins to ward off competitors. But efforts to draw more therapeutics from the ground have hit a snag. Most species cannot be grown ...

Researchers use immune system to attack glioblastoma

The Yale laboratory of Sidi Chen, assistant professor of genetics in the Systems Biology Institute and Yale Cancer Center, has developed advanced gene-editing and screening technology to find new targets for cancer immunotherapy.

Committee responds to critique of gene engineering report

Providing blanket approval or condemnation of all genetically engineered (GE) crops oversimplifies a complex issue and ignores the continued need for scrutiny, risk assessment and debate among various stakeholders – including ...

page 1 from 12

Nature Biotechnology

Nature Biotechnology (Nat Biotechnol; ISSN 1087-0156) is an academic journal covering the science and business of biotechnology.

Nature Biotechnology is a continuation of Bio/technology (Biotechnology (NY); ISSN 0733-222X), which was founded in 1983 and renamed in 1996. It is published monthly by the Nature Publishing Group, a division of Macmillan Publishers Ltd. Like other Nature journals, there is no external Editorial Board; editorial decisions are made by an in-house team, although peer review by external expert referees forms a part of the review process.

Its 2005 impact factor was 22.7, making it the highest cited research journal in the category of biotechnology and applied microbiology, and one of the 20 most highly cited scientific journals. In comparison, the impact factors of general science journals Science and Nature for the same period were 30.927 and 29.273, respectively.

The current editor of Nature Biotechnology is Andrew Marshall. The founding editor of Bio/technology was Christopher Edwards.

This text uses material from Wikipedia, licensed under CC BY-SA